doi: 10.1016/s0009-9236(02)17625-9.
Use of biomarkers from drug discovery through clinical practice: report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development
Affiliations
- PMID: 12709718
- DOI: 10.1016/s0009-9236(02)17625-9
Item in Clipboard
Use of biomarkers from drug discovery through clinical practice: report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development
Clin Pharmacol Ther.
2003 Apr.
No abstract available
Similar articles
-
Getting the Dose Right: report from the Tenth European Federation of Pharmaceutical Sciences (EUFEPS) conference on optimizing drug development.J Pharmacokinet Pharmacodyn. 2005 Apr;32(2):199-211. doi: 10.1007/s10928-005-0010-x. Epub 2005 Nov 7. J Pharmacokinet Pharmacodyn. 2005. PMID: 16283539
-
EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential - towards a consensus. European Federation of Pharmaceutical Sciences.Eur J Pharm Sci. 2001 Jul;13(4):417-28. doi: 10.1016/s0928-0987(01)00148-8. Eur J Pharm Sci. 2001. PMID: 11480400 No abstract available.
-
Organic chemistry in drug discovery.Science. 2004 Mar 19;303(5665):1810-3. doi: 10.1126/science.1096800. Science. 2004. PMID: 15031494
-
Drug metabolism and pharmacokinetics in support of drug design.Curr Pharm Des. 2009;15(19):2170-83. doi: 10.2174/138161209788682451. Curr Pharm Des. 2009. PMID: 19601821 Review.
-
Role of metabolism and pharmacokinetic studies in the discovery of new drugs--present and future perspectives.Xenobiotica. 1992 Jul;22(7):743-55. doi: 10.3109/00498259209053137. Xenobiotica. 1992. PMID: 1455898 Review.
Cited by
-
Future prospects for biomarkers of alcohol consumption and alcohol-induced disorders.Alcohol Clin Exp Res. 2010 Jun;34(6):946-54. doi: 10.1111/j.1530-0277.2010.01169.x. Epub 2010 Apr 5. Alcohol Clin Exp Res. 2010. PMID: 20374220 Free PMC article.
-
Pharmacokinetic and pharmacodynamic data to be derived from early-phase drug development: designing informative human pharmacology studies.Clin Pharmacokinet. 2008;47(6):373-81. doi: 10.2165/00003088-200847060-00002. Clin Pharmacokinet. 2008. PMID: 18479172 Review.
-
Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma.Blood. 2014 Aug 21;124(8):1259-65. doi: 10.1182/blood-2014-04-570044. Epub 2014 Jul 11. Blood. 2014. PMID: 25016003 Free PMC article. Clinical Trial.
-
Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance.Sensors (Basel). 2012;12(5):5596-607. doi: 10.3390/s120505596. Epub 2012 May 2. Sensors (Basel). 2012. PMID: 22778603 Free PMC article.
-
Harnessing pain heterogeneity and RNA transcriptome to identify blood-based pain biomarkers: a novel correlational study design and bioinformatics approach in a graded chronic constriction injury model.J Neurochem. 2012 Sep;122(5):976-94. doi: 10.1111/j.1471-4159.2012.07833.x. Epub 2012 Jul 9. J Neurochem. 2012. PMID: 22697386 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
